Innovative clinical trial design for pediatric therapeutics
- 1 September 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Clinical Pharmacology
- Vol. 4 (5), 643-652
- https://doi.org/10.1586/ecp.11.43
Abstract
Until approximately 15 years ago, sponsors rarely included children in the development of therapeutics. US and European legislation has resulted in an increase in the number of pediatric trials and specific label changes and dosing recommendations, although infants remain an understudied group. The lack of clinical trials in children is partly due to specific challenges in conducting trials in this patient population. Therapeutics in special populations, including premature infants, obese children and children receiving extracorporeal life support, are even less studied. National research networks in Europe and the USA are beginning to address some of the gaps in pediatric therapeutics using novel clinical trial designs. Recent innovations in pediatric clinical trial design, including sparse and scavenged sampling, population pharmacokinetic analyses and ‘opportunistic’ studies, have addressed some of the historical challenges associated with clinical trials in children.Keywords
This publication has 88 references indexed in Scilit:
- Oseltamivir Dosing for Influenza Infection in Premature NeonatesThe Journal of Infectious Diseases, 2010
- Impact of the CYP2C19*17 Allele on the Pharmacokinetics of Omeprazole and Pantoprazole in Children: Evidence for a Differential EffectDrug Metabolism and Disposition, 2010
- Safety and Transparency of Pediatric Drug TrialsArchives of Pediatrics & Adolescent Medicine, 2009
- Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young InfantsClinical Pharmacology & Therapeutics, 2009
- Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young InfantsThe Pediatric Infectious Disease Journal, 2009
- Pharmacokinetics of an Elevated Dosage of Micafungin in Premature NeonatesThe Pediatric Infectious Disease Journal, 2009
- Population Pharmacokinetics of Fluconazole in Young InfantsAntimicrobial Agents and Chemotherapy, 2008
- Morphine pharmacokinetics and pharmacodynamics in preterm and term neonates: secondary results from the NEOPAIN trialBritish Journal of Anaesthesia, 2008
- Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal DosingAntimicrobial Agents and Chemotherapy, 2007
- Peer-Reviewed Publication of Clinical Trials Completed for Pediatric ExclusivityJama-Journal Of The American Medical Association, 2006